Rallybio is a privately-held early-stage biotechnological research and development services intended to transform the lives of patients with a devastating disease. The company's services focus on small molecule and protein-based therapies in the late discovery to early clinical stages of drug development, enabling doctors to identify and accelerate the development of transformative breakthrough therapies for patients with severe and rare disorders.

New Haven, CT, USA

Farmington, CT, USA

Rallybio

Connecticut Innovations provides strategic capital and operational insight to push the frontiers of high-tech industries such as energy, biotechnology, information technology, and photonics. Over the years, CI has helped over 100 emerging companies research, develop, and market new products and services. This activity has attracted over $1 billion dollars in additional investments from private equity providers. CI has brought the State of Connecticut over $510 million in Gross State Profit and over 5,000 additional job-years.

Career Opportunities